On December 31, 2023, GSK will discontinue all strengths of Flovent HFA and Flovent Diskus. The authorized generics, fluticasone propionate HFA (generic for Flovent HFA) and fluticasone propionate diskus (generic for Flovent Diskus), will be added as preferred on the NC Medicaid Preferred Drug List (PDL) effective December 1, 2023.
According to the FDA, an authorized generic is an approved brand name drug that is marketed without the brand name on its label. Other than the fact that it does not have the brand name on its label, it is the exact same drug product as the branded product. Pharmacies can substitute the generic without an updated or new prescription. However, if an existing prescription for Flovent indicates brand medically necessary or dispense as written, the prescriber will need to provide a new prescription without that requirement so that the substitution is allowed.
Flovent HFA/Diskus will remain preferred so that claims will continue to pay until any remaining stock of the brand is depleted. (source)